WebJan 4, 2024 · The sample set reported a 15.3 per cent year-on-year (Y-o-Y) growth in domestic revenues, against a ~14.6 per cent Y-o-Y growth for the Indian pharmaceutical markets (IPM). WebApr 9, 2024 · The Indian Pharma Market (IPM) growth has normalised to 9.3 per cent in FY23, bringing it at par to the pre-pandemic years of FY19 and FY20. After a Covid-hit FY21 (when the IPM grew by only 2.2 per cent), the market posted a growth of 14.7 per cent in FY22, on a low base. Data from Pharmarack AWACS ...
Regulatory affairs courses & certification in India.
WebJul 13, 2024 · An insightful analysis on facility construction trends in the pharmaceutical industry for the last five years, highlighting facility construction projects established by top 20 pharma / biotech... WebJan 4, 2024 · In its latest report, ICRA has argued that Indian pharma could clock in 9-11% of growth in FY22, driven by a push from domestic and emerging markets in the next few … some cross highways
Indian pharma market back to pre-Covid level in FY23, says report
WebLead your pharma and medtech development projects. IPM will lead on-time product development projects for your core team or function, from research and development, to CMC, to commercialization and more. You can rely on us to make your process more efficient, even in the face of complex regulatory requirements. WebKollicream® IPM is a clear, colorless, almost odorless oil of medium polarity. On account of its high spreading value, the product is suitable for the application in pharmaceutical skin care preparations such as low-fatting emulsions and skin oils. Kollicream® IPM has a good solubilizing capacity for lipid-soluble active agents; it can serve ... WebPharmacist with the knowledge and compassion to deliver high quality pharmaceutical care Learn more about Mike Farr, PharmD's work … some current dimensions of aba